| Mar 03, 2026 | Michelle Greene | CHIEF INFORMATION OFFICER | -2.75K | $228.47 | -$627.39K | SELL | -18.34% | 12.23K | Feb 27 | View |
| Feb 18, 2026 | Aaron Alt | CHIEF FINANCIAL OFFICER | -4.24K | $223.37 | -$947.56K | SELL | -13.84% | 26.41K | Feb 15 - Feb 18 | View |
| Feb 10, 2026 | Hemingway Patricia Hall | DIRECTOR | -4.00K | $229.72 | -$918.88K | SELL | -12.40% | 28.26K | Feb 06 | View |
| Aug 20, 2025 | DEBORAH WEITZMAN | CEO, PSS SEGMENT | -21.37K | $150.53 | -$3.22M | SELL | -28.57% | 53.43K | Aug 20 | View |
| Aug 20, 2025 | Jason Hollar | CHIEF EXECUTIVE OFFICER | -35.90K | $150.04 | -$5.39M | SELL | -15.22% | 200.00K | Aug 20 | View |
| Aug 19, 2025 | Mary Scherer | CHIEF ACCOUNTING OFFICER | -8.13K | $149.52 | -$1.40M | SELL | -69.58% | 3.56K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Michelle Greene | CHIEF INFORMATION OFFICER | -19.99K | $149.41 | -$3.51M | SELL | -57.17% | 14.98K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Stephen Mason | CEO, GMPD SEGMENT | -63.43K | $149.41 | -$10.82M | SELL | -70.86% | 26.09K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Jason Hollar | CHIEF EXECUTIVE OFFICER | -201.33K | $149.64 | -$36.53M | SELL | -46.05% | 235.90K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Jessica Mayer | CHIEF LEGAL/COMPLIANCE OFFICER | -56.65K | $149.41 | -$9.86M | SELL | -53.90% | 48.46K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Aaron Alt | CHIEF FINANCIAL OFFICER | -71.75K | $149.38 | -$12.41M | SELL | -70.07% | 30.65K | Aug 15 - Aug 19 | View |
| Aug 19, 2025 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | -39.92K | $149.44 | -$6.92M | SELL | -71.93% | 15.57K | Aug 15 - Aug 19 | View |
| Nov 14, 2024 | Mary Scherer | CHIEF ACCOUNTING OFFICER | -3.50K | $123.55 | -$432.92K | SELL | -28.59% | 8.75K | Nov 14 | View |
| Aug 22, 2024 | Jessica Mayer | CHIEF LEGAL/COMPLIANCE OFFICER | -16.57K | $109.39 | -$1.81M | SELL | -17.91% | 75.97K | Aug 21 | View |
| Aug 19, 2024 | Jessica Mayer | CHIEF LEGAL/COMPLIANCE OFFICER | -18.52K | $89.63 | -$3.49M | SELL | -16.68% | 92.54K | Aug 15 - Aug 16 | View |
| Aug 19, 2024 | Aaron Alt | CHIEF FINANCIAL OFFICER | 9.47K | $108.39 | -$520.72K | GRANT | 34.55% | 36.87K | Aug 15 - Aug 19 | View |
| Aug 19, 2024 | Michelle Greene | CHIEF INFORMATION OFFICER | -3.03K | $107.92 | -$846.99K | SELL | -13.60% | 19.24K | Aug 15 - Aug 19 | View |
| Aug 19, 2024 | Jason Hollar | CHIEF EXECUTIVE OFFICER | -63.13K | $108.18 | -$12.04M | SELL | -24.21% | 197.64K | Aug 15 - Aug 19 | View |
| Aug 19, 2024 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | -26.57K | $92.83 | -$4.26M | SELL | -49.00% | 27.66K | Aug 15 - Aug 19 | View |
| Aug 19, 2024 | Stephen Mason | CEO, GMPD SEGMENT | -42.64K | $95.98 | -$6.29M | SELL | -51.18% | 40.67K | Aug 15 - Aug 19 | View |
| Nov 29, 2023 | DEBORAH WEITZMAN | CEO, PHARMACEUTICAL SEGMENT | -9.00K | $90.21 | -$1.85M | SELL | -20.36% | 35.20K | Nov 27 | View |
| Aug 29, 2023 | DEBORAH WEITZMAN | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $80.62 | -$123.37K | SELL-OPTIONS | 0.00% | 44.20K | Aug 28 | View |
| Aug 21, 2023 | Mary Scherer | CHIEF ACCOUNTING OFFICER | -9.23K | $80.82 | -$921.71K | SELL | -46.44% | 10.65K | Aug 18 | View |
| Aug 17, 2023 | Jessica Mayer | CHIEF LEGAL/COMPLIANCE OFFICER | -45.43K | $84.17 | -$5.37M | SELL | -34.87% | 84.86K | Aug 15 - Aug 17 | View |
| Aug 17, 2023 | Stephen Mason | CEO, MEDICAL SEGMENT | -49.93K | $89.63 | -$5.66M | SELL | -57.20% | 37.35K | Aug 15 - Aug 17 | View |
| Aug 17, 2023 | Michelle Greene | CHIEF INFORMATION OFFICER | 7.16K | $89.16 | -$288.79K | GRANT | 52.43% | 20.81K | Aug 15 - Aug 17 | View |
| Aug 17, 2023 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | -28.03K | $80.43 | -$3.42M | SELL | -52.50% | 25.36K | Aug 15 - Aug 17 | View |
| Aug 08, 2023 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | 23.29K | $50.35 | $16.31K | BUY | 77.39% | 53.39K | Oct 15 - Aug 07 | View |
| Nov 16, 2022 | Michelle Brennan | DIRECTOR | 400.00 | $75.51 | $30.20K | BUY | 13.68% | 3.32K | Nov 14 - Nov 15 | View |
| Nov 10, 2022 | Michelle Brennan | DIRECTOR | 2.46K | $79.74 | $11.96K | BUY | 527.47% | 2.92K | Nov 09 - Nov 10 | View |
| Nov 09, 2022 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | -20.22K | $78.87 | -$1.55M | SELL | -39.71% | 30.70K | Nov 07 | View |
| Nov 09, 2022 | Stephen Mason | CEO, MEDICAL SEGMENT | -44.35K | $74.34 | -$3.81M | SELL | -47.51% | 49.00K | Nov 07 | View |
| Nov 19, 2021 | Ola Snow | CHIEF HUMAN RESOURCES OFFICER | -10.00K | $49.17 | -$491.70K | SELL | -21.23% | 37.11K | Nov 18 | View |
| Mar 01, 2021 | Jessica Mayer | CHIEF LEGAL/COMPLIANCE OFFICER | -3.50K | $51.53 | -$180.35K | SELL | -21.72% | 12.62K | Feb 26 | View |
| Feb 12, 2021 | Patricia English | CHIEF ACCOUNTING OFFICER | -3.29K | $51.98 | -$171.07K | SELL | -35.10% | 6.08K | Feb 11 | View |
| Nov 13, 2018 | STUART LAWS | SVP & CHIEF ACCOUNTING OFFICER | -804.00 | $55.55 | -$44.66K | SELL | -11.32% | 6.30K | Nov 12 - Nov 13 | View |
| Aug 21, 2018 | Jon Giacomin | CEO, MEDICAL SEGMENT | -2.89K | $51.95 | -$150.14K | SELL | -3.83% | 72.65K | Aug 20 | View |
| Feb 20, 2018 | Jon Giacomin | CEO, MEDICAL SEGMENT | 6.69K | $68.78 | -$549.92K | GRANT | 13.83% | 55.05K | Feb 15 - Feb 20 | View |
| Feb 16, 2018 | PATRICIA MORRISON | CHIEF INFORMATION OFFICER | -29.71K | $66.34 | -$1.97M | SELL | -45.93% | 34.98K | Feb 14 - Feb 15 | View |
| Jan 23, 2018 | Michael Kaufmann | CHIEF EXECUTIVE OFFICER | -18.59K | $73.90 | -$1.37M | SELL | -8.07% | 211.86K | Jan 22 | View |
| May 15, 2017 | Jon Giacomin | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $57.23 | -$727.65K | SELL-OPTIONS | 0.00% | 32.17K | May 12 | View |
| Feb 13, 2017 | George Barrett | CHAIRMAN AND CEO | 0.00 | $54.09 | -$10.09M | SELL-OPTIONS | 0.00% | 464.23K | Feb 10 | View |
| Nov 14, 2016 | George Barrett | CHAIRMAN AND CEO | 0.00 | $51.12 | -$8.80M | SELL-OPTIONS | 0.00% | 464.23K | Nov 10 | View |
| Aug 22, 2016 | STUART LAWS | SVP & CHIEF ACCOUNTING OFFICER | -9.70K | $82.45 | -$800.01K | SELL | -78.12% | 2.72K | Aug 18 | View |
| Aug 22, 2016 | PATRICIA MORRISON | CHIEF INFORMATION OFFICER | 0.00 | $61.16 | -$1.88M | SELL-OPTIONS | 0.00% | 55.70K | Aug 18 | View |
| Aug 17, 2016 | Jon Giacomin | CEO, PHARMACEUTICAL SEGMENT | -163.00 | $55.52 | -$3.13M | SELL | -0.49% | 33.02K | Aug 15 - Aug 16 | View |
| Aug 15, 2016 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | -12.70K | $83.13 | -$1.06M | SELL | -12.27% | 90.81K | Aug 11 | View |
| Aug 10, 2016 | George Barrett | CHAIRMAN AND CEO | 0.00 | $57.29 | -$13.17M | SELL-OPTIONS | 0.00% | 490.33K | Aug 08 - Aug 10 | View |
| Aug 10, 2016 | Donald Casey Jr | CEO, MEDICAL SEGMENT | 0.00 | $62.09 | -$2.55M | SELL-OPTIONS | 0.00% | 138.32K | Aug 09 - Aug 10 | View |
| May 23, 2016 | CAROLE WATKINS | CHIEF HR OFFICER | 0.00 | $52.31 | -$4.23M | SELL-OPTIONS | 0.00% | 33.99K | May 20 | View |
| Nov 12, 2015 | George Barrett | CHAIRMAN AND CEO | 0.00 | $57.51 | -$3.30M | SELL-OPTIONS | 0.00% | 406.13K | Nov 10 | View |
| Nov 09, 2015 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | -75.00 | $69.80 | -$1.07M | SELL | -0.22% | 33.63K | Aug 28 - Nov 06 | View |
| Aug 20, 2015 | George Barrett | CHAIRMAN AND CEO | 0.00 | $55.19 | -$16.74M | SELL-OPTIONS | 0.00% | 406.13K | Aug 20 | View |
| Aug 07, 2015 | DAVID ANDERSON | DIRECTOR | 1.40K | $86.41 | $120.97K | BUY | ∞ | 400.00 | Aug 06 | View |
| May 12, 2015 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | 0.00 | $63.45 | -$1.79M | SELL-OPTIONS | 0.00% | 29.06K | May 12 | View |
| May 12, 2015 | George Barrett | CHAIRMAN AND CEO | 0.00 | $56.86 | -$17.75M | SELL-OPTIONS | 0.00% | 348.69K | May 11 | View |
| May 12, 2015 | PATRICIA MORRISON | CHIEF INFORMATION OFFICER | 0.00 | $63.91 | -$1.61M | SELL-OPTIONS | 0.00% | 30.80K | May 08 | View |
| Mar 04, 2015 | CALVIN DARDEN | DIRECTOR | 0.00 | $58.32 | -$578.75K | SELL-OPTIONS | 0.00% | 22.77K | Mar 03 | View |
| Mar 04, 2015 | RICHARD NOTEBAERT | DIRECTOR | 0.00 | $58.50 | -$582.18K | SELL-OPTIONS | 0.00% | 35.78K | Mar 03 | View |
| Mar 04, 2015 | Colleen Arnold | DIRECTOR | 0.00 | $58.23 | -$576.79K | SELL-OPTIONS | 0.00% | 21.60K | Mar 04 | View |
| Feb 23, 2015 | CAROLE WATKINS | CHIEF HR OFFICER | 0.00 | $57.14 | -$2.02M | SELL-OPTIONS | 0.00% | 31.87K | Feb 20 | View |
| Feb 11, 2015 | CAROLE WATKINS | CHIEF HR OFFICER | -81.00 | $56.14 | -$2.93M | SELL | -0.25% | 31.87K | Nov 24 - Feb 10 | View |
| Feb 11, 2015 | George Barrett | CHAIRMAN AND CEO | -24.39K | $56.08 | -$17.27M | SELL | -6.54% | 348.69K | Dec 03 - Feb 10 | View |
| Nov 10, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -2.18K | $61.71 | -$973.45K | SELL | -9.65% | 20.41K | Nov 07 | View |
| Sep 08, 2014 | CAROLE WATKINS | CHIEF HR OFFICER | 0.00 | $58.05 | -$1.38M | SELL-OPTIONS | 0.00% | 31.94K | Sep 05 | View |
| Sep 05, 2014 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $58.03 | -$1.70M | SELL-OPTIONS | 0.00% | 118.58K | Sep 04 | View |
| Aug 28, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 0.00 | $62.06 | -$561.63K | SELL-OPTIONS | 0.00% | 67.19K | Aug 27 | View |
| Aug 26, 2014 | DAVID KING | DIRECTOR | -30.00 | $73.55 | -$2.21K | SELL | -0.25% | 12.10K | Aug 25 | View |
| Aug 19, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -5.22K | $72.14 | -$587.38K | SELL | -18.79% | 22.59K | Aug 15 - Aug 18 | View |
| Aug 19, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -5.81K | $56.36 | -$4.20M | SELL | -7.96% | 67.19K | Aug 15 - Aug 18 | View |
| Aug 19, 2014 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -8.82K | $72.11 | -$1.48M | SELL | -6.92% | 118.58K | Aug 15 - Aug 18 | View |
| Aug 11, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -24.17K | $55.33 | -$4.39M | SELL | -24.87% | 73.00K | Aug 08 | View |
| Aug 11, 2014 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | -4.97K | $55.52 | -$1.46M | SELL | -6.75% | 68.76K | Aug 08 | View |
| Jul 28, 2014 | STUART LAWS | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $51.72 | -$883.81K | SELL-OPTIONS | 0.00% | 5.78K | Jul 24 | View |
| Jul 28, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | 0.00 | $57.18 | -$750.12K | SELL-OPTIONS | 0.00% | 24.42K | Jul 24 | View |
| Jul 15, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -23.63K | $70.65 | -$1.67M | SELL | -22.07% | 83.46K | Jul 14 | View |
| May 20, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -4.70K | $66.50 | -$312.75K | SELL | -16.15% | 24.42K | May 19 | View |
| May 14, 2014 | George Barrett | CHAIRMAN AND CEO | 0.00 | $54.60 | -$175.73K | SELL-OPTIONS | 0.00% | 334.10K | May 12 | View |
| May 14, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -2.82K | $66.50 | -$187.66K | SELL | -8.84% | 29.12K | May 13 | View |
| May 08, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -27.03K | $63.83 | -$1.73M | SELL | -20.15% | 107.10K | May 07 | View |
| Feb 11, 2014 | George Barrett | CHAIRMAN AND CEO | 0.00 | $55.40 | -$4.50M | SELL-OPTIONS | 0.00% | 334.10K | Feb 10 | View |
| Feb 11, 2014 | CAROLE WATKINS | CHIEF HR OFFICER | -28.26K | $67.01 | -$1.89M | SELL | -50.57% | 27.62K | Feb 07 | View |
| Feb 11, 2014 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $48.23 | -$14.96M | SELL-OPTIONS | 0.00% | 115.97K | Feb 10 - Feb 11 | View |
| Feb 11, 2014 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -2.33K | $68.53 | -$159.67K | SELL | -6.80% | 31.94K | Feb 11 | View |
| Feb 05, 2014 | RICHARD NOTEBAERT | DIRECTOR | 0.00 | $53.81 | -$254.60K | SELL-OPTIONS | 0.00% | 33.75K | Feb 04 | View |
| Feb 05, 2014 | GREGORY KENNY | DIRECTOR | 0.00 | $51.05 | -$521.10K | SELL-OPTIONS | 0.00% | 19.58K | Feb 05 | View |
| Feb 05, 2014 | JOHN FINN | DIRECTOR | -2.25K | $53.81 | -$254.60K | SELL | -9.66% | 21.02K | Dec 20 - Feb 04 | View |
| Feb 05, 2014 | CALVIN DARDEN | DIRECTOR | 0.00 | $54.85 | -$111.77K | SELL-OPTIONS | 0.00% | 20.74K | Feb 05 | View |
| Feb 05, 2014 | Colleen Arnold | DIRECTOR | 0.00 | $56.01 | -$156.24K | SELL-OPTIONS | 0.00% | 19.57K | Feb 04 | View |
| Feb 05, 2014 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | -10.00K | $53.33 | -$849.47K | SELL | -29.21% | 24.24K | Feb 04 | View |
| Feb 05, 2014 | CAROLE WATKINS | CHIEF HR OFFICER | -358.00 | $48.63 | -$1.59M | SELL | -0.64% | 55.87K | Feb 03 - Feb 04 | View |
| Feb 05, 2014 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | -13.17K | $54.03 | -$1.25M | SELL | -16.15% | 68.39K | Feb 03 | View |
| Feb 05, 2014 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -33.10K | $49.06 | -$10.20M | SELL | -19.79% | 134.13K | Feb 03 | View |
| Nov 12, 2013 | George Barrett | CHAIRMAN AND CEO | 0.00 | $52.56 | -$4.06M | SELL-OPTIONS | 0.00% | 334.10K | Nov 11 | View |
| Oct 01, 2013 | STUART LAWS | SVP & CHIEF ACCOUNTING OFFICER | -989.00 | $40.54 | -$599.30K | SELL | -14.62% | 5.78K | Sep 30 | View |
| Sep 12, 2013 | Mark Blake | EVP - STRATEGY & CORP. DEV. | 3.63K | $41.23 | -$187.97K | SELL-OPTIONS | 11.85% | 34.27K | Sep 11 | View |
| Aug 20, 2013 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -4.92K | $51.27 | -$252.50K | SELL | -13.85% | 30.64K | Aug 19 | View |
| Aug 19, 2013 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | -18.67K | $51.42 | -$1.16M | SELL | -18.63% | 81.55K | Aug 14 - Aug 16 | View |
| Aug 19, 2013 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | -8.04K | $51.64 | -$644.88K | SELL | -19.01% | 34.24K | Aug 15 - Aug 16 | View |
| Aug 15, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 1.42K | $50.62 | -$79.79K | SELL-OPTIONS | 0.85% | 167.39K | Aug 13 | View |
| Aug 15, 2013 | George Barrett | CHAIRMAN AND CEO | -75.00K | $52.09 | -$3.91M | SELL | -18.71% | 325.79K | Aug 13 | View |
| Aug 12, 2013 | CALVIN DARDEN | DIRECTOR | 0.00 | $48.98 | -$16.24K | SELL-OPTIONS | 0.00% | 18.13K | Aug 08 | View |
| Aug 07, 2013 | Mark Blake | EVP - STRATEGY & CORP. DEV. | 7.26K | $41.23 | -$375.87K | SELL-OPTIONS | 28.50% | 32.74K | Aug 05 | View |
| Jul 29, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 23.22K | $39.14 | -$1.19M | SELL-OPTIONS | 17.61% | 155.08K | Jul 26 | View |
| Jul 22, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 756.00 | $49.28 | -$44.52K | SELL-OPTIONS | 0.58% | 131.87K | Jul 18 | View |
| Jul 17, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 193.00 | $49.28 | -$11.29K | SELL-OPTIONS | 0.15% | 131.11K | Jul 15 | View |
| Jul 15, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | 23.63K | $38.14 | -$1.16M | SELL-OPTIONS | 22.03% | 130.92K | Jul 11 | View |
| Jun 20, 2013 | JOHN FINN | DIRECTOR | -2.81K | $46.51 | -$169.66K | SELL | -10.79% | 23.27K | Jun 19 | View |
| May 29, 2013 | JEAN SPAULDING | DIRECTOR | 186.00 | $46.24 | -$10.30K | SELL-OPTIONS | 1.09% | 17.18K | May 24 - May 28 | View |
| May 23, 2013 | RICHARD NOTEBAERT | DIRECTOR | 57.00 | $47.30 | -$2.50K | SELL-OPTIONS | 0.18% | 31.14K | May 22 | View |
| May 23, 2013 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -36.00 | $47.52 | -$1.71K | SELL | -0.03% | 104.33K | May 22 | View |
| May 21, 2013 | CAROLE WATKINS | CHIEF HR OFFICER | 1.88K | $35.45 | -$72.66K | SELL-OPTIONS | 4.13% | 47.45K | May 20 | View |
| May 21, 2013 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | 14.45K | $37.64 | -$558.28K | SELL-OPTIONS | 17.86% | 95.33K | May 20 | View |
| May 21, 2013 | JEAN SPAULDING | DIRECTOR | -1.67K | $47.90 | -$79.80K | SELL | -8.93% | 17.00K | May 20 | View |
| May 15, 2013 | SMITH CARRIE COX | DIRECTOR | 435.00 | $46.25 | $20.12K | BUY | 3.18% | 14.13K | May 14 | View |
| May 08, 2013 | CAROLE WATKINS | CHIEF HR OFFICER | -21.39K | $34.42 | -$1.05M | SELL | -31.95% | 45.57K | May 06 - May 07 | View |
| May 08, 2013 | Mark Blake | EVP - STRATEGY & CORP. DEV. | 7.53K | $36.95 | -$347.60K | SELL-OPTIONS | 41.91% | 25.48K | May 07 | View |
| May 08, 2013 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | -14.25K | $46.14 | -$657.63K | SELL | -26.48% | 39.58K | May 06 | View |
| May 08, 2013 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | 10.79K | $36.71 | -$571.00K | SELL-OPTIONS | 15.40% | 80.88K | May 07 - May 08 | View |
| May 08, 2013 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -2.63K | $40.06 | -$2.63M | SELL | -2.39% | 107.28K | May 06 - May 07 | View |
| May 08, 2013 | RICHARD NOTEBAERT | DIRECTOR | 0.00 | $44.73 | -$15.20K | SELL-OPTIONS | 0.00% | 31.08K | May 06 | View |
| May 08, 2013 | JEAN SPAULDING | DIRECTOR | 0.00 | $43.78 | -$50.30K | SELL-OPTIONS | 0.00% | 18.66K | May 06 | View |
| Jan 25, 2013 | Craig Morford | CHIEF LEGAL/COMPLIANCE OFFICER | 13.17K | $36.14 | -$477.90K | SELL-OPTIONS | 23.13% | 70.09K | Jan 23 | View |
| Jan 25, 2013 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -3.50K | $36.12 | -$1.12M | SELL | -3.25% | 104.36K | Dec 03 - Jan 23 | View |
| Jan 25, 2013 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | 10.88K | $36.14 | -$395.06K | SELL-OPTIONS | 25.35% | 53.83K | Jan 23 | View |
| Jan 14, 2013 | Falk Stephen | EVP, GEN. COUNSEL & CORP. SEC. | 10.10K | $35.14 | -$350.74K | SELL-OPTIONS | 30.74% | 42.95K | Jan 10 | View |
| Jan 14, 2013 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -1.47K | $42.92 | -$63.14K | SELL | -7.57% | 17.95K | Jan 10 | View |
| Dec 17, 2012 | Mark Blake | EVP - STRATEGY & CORP. DEV. | -2.33K | $42.25 | -$98.44K | SELL | -10.71% | 19.43K | Dec 14 | View |
| Nov 05, 2012 | STUART LAWS | SVP & CHIEF ACCOUNTING OFFICER | -2.56K | $41.22 | -$105.69K | SELL | -33.24% | 5.15K | Nov 01 | View |
| Oct 09, 2012 | Jeffrey W. Henderson | CHIEF FINANCIAL OFFICER | 3.77K | $33.64 | -$484.54K | SELL-OPTIONS | 3.56% | 109.91K | Oct 04 | View |
| Sep 11, 2012 | William Jeffrey Henderson | CHIEF FINANCIAL OFFICER | -29.41K | $32.81 | -$1.68M | SELL | -21.05% | 110.28K | Sep 07 - Sep 10 | View |
| May 21, 2012 | JEAN SPAULDING | DIRECTOR | 1.67K | $35.43 | -$59.89K | SELL-OPTIONS | 12.13% | 15.41K | May 17 | View |
| Feb 29, 2012 | Michael Lynch | CEO, MEDICAL SEGMENT | 8.03K | $34.64 | -$242.44K | SELL-OPTIONS | 9.89% | 89.20K | Feb 27 | View |
| Feb 27, 2012 | Michael Lynch | CEO, MEDICAL SEGMENT | -8.00K | $36.93 | -$632.83K | SELL | -8.97% | 81.18K | Feb 24 | View |
| Oct 28, 2011 | Michael C Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 11.99K | $36.12 | -$434.96K | SELL-OPTIONS | 15.24% | 90.68K | Oct 26 - Oct 27 | View |
| Oct 20, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | -1.34K | $42.40 | -$56.86K | SELL | -17.34% | 6.39K | Oct 19 | View |
| Sep 15, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | -1.50K | $41.23 | -$61.68K | SELL | -16.21% | 7.73K | Sep 14 - Sep 15 | View |
| Aug 17, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | 143.00 | $41.54 | -$70.46K | GRANT | 1.57% | 9.23K | Aug 15 - Aug 17 | View |
| Jul 14, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | -1.10K | $46.68 | -$51.35K | SELL | -10.80% | 9.09K | Jul 13 | View |
| Jul 08, 2011 | Stephen T. Falk | EVP, GEN. COUNSEL & CORP. SEC. | 2.50K | $39.20 | -$95.07K | SELL-OPTIONS | 11.34% | 24.51K | Jul 07 | View |
| Jul 08, 2011 | JOHN FINN | DIRECTOR | -2.86K | $46.50 | -$133.18K | SELL | -6.91% | 38.56K | Jul 06 | View |
| Jul 05, 2011 | Carole S Watkins | CHIEF HR OFFICER | 2.58K | $34.45 | -$95.69K | SELL-OPTIONS | 4.72% | 57.14K | Jul 01 | View |
| Jul 05, 2011 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $39.14 | -$138.15K | SELL-OPTIONS | 0.00% | 62.19K | Jul 01 | View |
| Jun 16, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | -1.10K | $43.79 | -$48.17K | SELL | -9.75% | 10.19K | Jun 15 | View |
| May 20, 2011 | Jeffrey W. Henderson | CHIEF FINANCIAL OFFICER | -10.55K | $42.47 | -$740.87K | SELL | -8.61% | 112.05K | May 19 | View |
| May 13, 2011 | Stuart G Laws | SVP & CHIEF ACCOUNTING OFFICER | -1.02K | $44.96 | -$46.08K | SELL | -8.33% | 11.29K | May 11 | View |
| May 09, 2011 | Stephen T. Falk | EVP, GEN. COUNSEL & CORP. SEC. | -3.52K | $33.95 | -$234.22K | SELL | -13.77% | 22.02K | May 05 | View |
| May 09, 2011 | Michael C Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $38.64 | -$128.00K | SELL-OPTIONS | 0.00% | 62.19K | May 05 | View |
| Apr 27, 2011 | Michael C Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $38.14 | -$117.86K | SELL-OPTIONS | 0.00% | 62.19K | Apr 27 | View |
| Apr 27, 2011 | Stephen T. Falk | EVP, GEN. COUNSEL & CORP. SEC. | 786.00 | $32.95 | -$27.57K | SELL-OPTIONS | 3.18% | 25.53K | Apr 26 | View |
| Apr 27, 2011 | Jeffrey W. Henderson | CHIEF FINANCIAL OFFICER | 0.00 | $41.34 | -$196.00K | SELL-OPTIONS | 0.00% | 122.60K | Apr 26 | View |
| Apr 25, 2011 | Michael C Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -8.56K | $42.95 | -$367.65K | SELL | -12.10% | 62.19K | Apr 21 | View |
| Mar 21, 2011 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $31.93 | -$3.19K | SELL-OPTIONS | 0.00% | 70.75K | Mar 18 | View |
| Feb 08, 2011 | Michael C Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -6.90K | $33.81 | -$1.56M | SELL | -8.88% | 70.75K | Feb 07 | View |
| Dec 07, 2010 | Michael Kaufmann | CEO, PHARMACEUTICAL SEGMENT | -633.00 | $37.29 | -$23.60K | SELL | -95.19% | 32.00 | Dec 03 | View |
| Aug 24, 2009 | Carole S Watkins | CHIEF HR OFFICER | 0.00 | $32.92 | -$46.17K | SELL-OPTIONS | 0.00% | 41.13K | Aug 20 | View |
| Aug 24, 2009 | RICHARD NOTEBAERT | DIRECTOR | 0.00 | $33.92 | -$6.46K | SELL-OPTIONS | 0.00% | 16.32K | Aug 20 | View |
| Aug 24, 2009 | JOHN FINN | DIRECTOR | 461.00 | $32.38 | -$148.57 | SELL-OPTIONS | 1.26% | 37.09K | Aug 20 | View |
| Nov 27, 2007 | R. Kerry Clark | CHAIRMAN AND CEO | 20.00K | $57.50 | $1.15M | BUY | 13.10% | 172.68K | Nov 26 | View |
| Nov 16, 2007 | MATTHEW WALTER | DIRECTOR | -58.90K | $59.92 | -$3.53M | SELL | -6.09% | 907.66K | Nov 14 | View |
| Nov 16, 2007 | MATTHEW WALTER | DIRECTOR | -36.10K | $60.19 | -$1.87M | SELL | -3.34% | 1.05M | Nov 13 - Nov 14 | View |
| Jun 06, 2007 | Eric Slusser | EVP, CAO & CONTROLLER | 0.00 | $65.35 | -$290.86K | SELL-OPTIONS | 0.00% | 8.57K | Jun 04 | View |
| Jun 06, 2007 | Matthew D Walter | DIRECTOR | -7.00K | $72.73 | -$508.89K | SELL | -6.81% | 95.72K | Jun 04 | View |
| Apr 23, 2007 | Carole S Watkins | CHIEF HR OFFICER | 0.00 | $56.88 | -$203.73K | SELL-OPTIONS | 0.00% | 14.21K | Apr 20 | View |
| Apr 04, 2007 | David L Schlotterbeck | CEO - PHARM & MED PRODUCTS | -375.00 | $73.00 | -$27.38K | SELL | -24.15% | 1.18K | Apr 02 | View |
| Mar 01, 2007 | Jean G Spaulding | DIRECTOR | -485.00 | $70.21 | -$34.05K | SELL | -43.77% | 623.00 | Mar 01 | View |
| Feb 13, 2007 | John B McCoy | DIRECTOR | 27.98K | $52.03 | -$112.69K | SELL-OPTIONS | 100.57% | 55.80K | Dec 07 - Feb 12 | View |
| Feb 13, 2007 | Robert L Gerbig | DIRECTOR | 0.00 | $51.84 | -$257.69K | SELL-OPTIONS | 0.00% | 66.22K | Feb 12 - Feb 13 | View |
| Jan 29, 2007 | Matthew D Walter | DIRECTOR | -23.13K | $72.50 | -$1.81M | SELL | -20.12% | 91.80K | Jan 09 - Jan 25 | View |
| Dec 15, 2006 | Robert D Walter | EXEC. CHAIRMAN THE BOARD | 0.00 | $46.11 | -$762.42K | SELL-OPTIONS | 0.00% | 1.64M | Dec 14 - Dec 15 | View |
| Dec 13, 2006 | Robert D Walter | EXEC. CHAIRMAN THE BOARD | 0.00 | $46.42 | -$774.58K | SELL-OPTIONS | 0.00% | 1.64M | Dec 12 - Dec 13 | View |
| Dec 11, 2006 | Matthew D Walter | DIRECTOR | -90.00K | $65.90 | -$5.93M | SELL | -7.48% | 1.11M | Dec 11 | View |
| Dec 11, 2006 | Robert D Walter | EXEC. CHAIRMAN THE BOARD | -2.13K | $46.48 | -$388.46K | SELL | -0.13% | 1.64M | Aug 30 - Dec 11 | View |
| Dec 04, 2006 | Matthew D Walter | DIRECTOR | -10.00K | $65.77 | -$657.65K | SELL | -5.47% | 172.80K | Dec 04 | View |
| Aug 22, 2006 | Brendan A Ford | EVP-CORPORATE DEVELOPMENT | 0.00 | $47.32 | -$419.50K | SELL-OPTIONS | 0.00% | 90.23K | Aug 18 - Aug 21 | View |
| Aug 22, 2006 | David L Schlotterbeck | CEO - PHARM & MED PRODUCTS | -20.00K | $67.51 | -$1.35M | SELL | -29.27% | 48.32K | Aug 18 | View |
| May 18, 2006 | Ronald K Labrum | CEO-SUPPLY CHAIN SVCS. | 0.00 | $49.73 | -$1.39M | SELL-OPTIONS | 0.00% | 38.90K | May 16 | View |
| May 18, 2006 | Carole S Watkins | EVP - HUMAN RESOURCES | -210.00 | $68.01 | -$11.90K | SELL | -4.46% | 4.50K | Mar 20 - May 16 | View |
| May 17, 2006 | Matthew D Walter | DIRECTOR | -5.30K | $67.80 | -$474.40K | SELL | -6.35% | 78.13K | Jan 11 - May 15 | View |
| Feb 09, 2006 | George L Fotiades | PRESIDENT & COO | 39.00 | $62.76 | $2.45K | BUY | 0.05% | 80.28K | Oct 15 - Jan 15 | View |
| Feb 01, 2006 | Ronald K Labrum | CEO-HEALTHCARE SUPPLY CHN SVC | 0.00 | $42.18 | -$1.17M | SELL-OPTIONS | 0.00% | 38.90K | Feb 01 | View |
| Dec 06, 2005 | Ronald K Labrum | CEO-HEALTHCARE SUPPLY CHN SVC | 0.00 | $37.42 | -$2.55M | SELL-OPTIONS | 0.00% | 38.90K | Dec 05 | View |
| Nov 30, 2005 | David L Schlotterbeck | CHMN & CEO-CLNCL TECHN & SVCS | -32.00K | $64.30 | -$2.06M | SELL | -32.52% | 66.41K | Nov 30 | View |
| Nov 03, 2005 | Mark W Parrish | COO-PHARM SUPPLY CHN SVCS | 0.00 | $39.88 | -$69.30K | SELL-OPTIONS | 0.00% | 25.16K | Nov 01 | View |
| Oct 27, 2005 | Ronald K Labrum | CEO-HEALTHCARE SUPPLY CHN SVC | 0.00 | $37.42 | -$55.71K | SELL-OPTIONS | 0.00% | 38.90K | Oct 25 | View |
| Oct 05, 2005 | Mark W Parrish | COO-PHARM SUPPLY CHN SVCS | 0.00 | $40.47 | -$71.14K | SELL-OPTIONS | 0.00% | 25.16K | Oct 03 | View |
| Sep 12, 2005 | Robert D Walter | CHAIRMAN AND CEO | -10.00K | $59.60 | -$596.00K | SELL | -0.44% | 2.27M | Sep 12 | View |
| Sep 06, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 7.44K | $38.53 | -$65.08K | SELL-OPTIONS | 41.98% | 25.16K | Sep 01 - Sep 02 | View |
| Aug 10, 2005 | Robert D Walter | CHAIRMAN AND CEO | -65.00K | $59.15 | -$3.84M | SELL | -2.83% | 2.23M | Aug 10 | View |
| Aug 03, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $38.70 | -$65.60K | SELL-OPTIONS | 0.00% | 17.72K | Aug 01 | View |
| Jul 11, 2005 | Robert D Walter | CHAIRMAN AND CEO | -65.00K | $57.97 | -$3.77M | SELL | -2.75% | 2.29M | Jul 11 | View |
| Jul 06, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $37.63 | -$62.26K | SELL-OPTIONS | 0.00% | 17.72K | Jul 01 | View |
| Jun 22, 2005 | Ronald K Labrum | CEO-INT PROV SOL & CAH INT'L | 0.00 | $34.92 | -$2.37M | SELL-OPTIONS | 0.00% | 14.38K | Jun 20 | View |
| Jun 10, 2005 | Robert D Walter | CHAIRMAN AND CEO | -65.00K | $57.31 | -$3.72M | SELL | -2.68% | 2.36M | Jun 10 | View |
| Jun 03, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $37.83 | -$62.88K | SELL-OPTIONS | 0.00% | 17.72K | Jun 01 | View |
| May 31, 2005 | George L Fotiades | PRESIDENT & COO | 0.00 | $48.03 | -$1.43M | SELL-OPTIONS | 0.00% | 80.40K | May 31 | View |
| May 10, 2005 | Robert D Walter | CHAIRMAN AND CEO | -99.50K | $55.66 | -$3.62M | SELL | -3.94% | 2.42M | Apr 23 - May 10 | View |
| May 05, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $36.87 | -$59.88K | SELL-OPTIONS | 0.00% | 17.72K | May 04 | View |
| Apr 11, 2005 | Robert D Walter | CHAIRMAN AND CEO | -65.00K | $55.52 | -$3.61M | SELL | -2.71% | 2.33M | Apr 11 | View |
| Apr 06, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $36.87 | -$59.88K | SELL-OPTIONS | 0.00% | 17.72K | Apr 04 | View |
| Mar 10, 2005 | Robert D Walter | CHAIRMAN AND CEO | -65.00K | $57.21 | -$3.72M | SELL | -2.35% | 2.70M | Mar 10 | View |
| Mar 02, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 0.00 | $38.19 | -$64.02K | SELL-OPTIONS | 0.00% | 17.72K | Mar 01 | View |
| Feb 22, 2005 | Mark W Parrish | CHMN & CEO-PDPS | 8.95K | $35.98 | -$247.17K | SELL-OPTIONS | 101.94% | 17.72K | Feb 17 | View |
| Feb 17, 2005 | John F Havens | DIRECTOR | -9.57K | $57.47 | -$549.98K | SELL | -24.54% | 29.43K | Feb 16 | View |
| Feb 17, 2005 | Jody R Davids | EVP & CIO | 0.00 | $44.93 | -$119.70K | SELL-OPTIONS | 0.00% | 1.71K | Feb 16 | View |
| Feb 16, 2005 | Matthew D Walter | DIRECTOR | -5.85K | $57.00 | -$443.18K | SELL | -4.27% | 131.10K | Feb 14 - Feb 16 | View |
| Feb 07, 2005 | Brendan A Ford | EVP - CORP. DEVELOPMENT | 3.87K | $37.33 | -$226.98K | SELL-OPTIONS | 6.20% | 66.25K | Feb 03 | View |
| Dec 08, 2004 | Ronald K Labrum | CEO-INT PROV SOL & CAH INT'L | 0.00 | $30.87 | -$1.99M | SELL-OPTIONS | 0.00% | 14.38K | Dec 06 | View |
| Nov 12, 2004 | George L Fotiades | PRESIDENT & COO | 38.13K | $39.07 | -$1.66M | SELL-OPTIONS | 90.18% | 80.40K | Nov 10 | View |
| Aug 25, 2004 | Brendan A Ford | EVP - CORP. DEVELOPMENT | 40.00 | $43.77 | $1.75K | BUY | 0.06% | 62.38K | Aug 02 | View |
| May 04, 2004 | Gary S Jensen | SVP - CORPORATE CONTROLLER | 0.00 | $50.42 | -$295.89K | SELL-OPTIONS | 0.00% | 612.00 | May 03 | View |
| Mar 10, 2004 | Gary S Jensen | SVP - CORPORATE CONTROLLER | 0.00 | $46.02 | -$185.87K | SELL-OPTIONS | 0.00% | 612.00 | Mar 08 | View |
| Mar 05, 2004 | John B McCoy | DIRECTOR | 0.00 | $40.12 | -$195.83K | SELL-OPTIONS | 0.00% | 50.77K | Mar 04 | View |
| Feb 25, 2004 | Jean G Spaulding | DIRECTOR | 150.00 | $64.10 | $9.62K | BUY | 15.32% | 1.13K | Feb 24 | View |
| Feb 25, 2004 | Stephen S Thomas | EVP-GROUP PRES.-AIS | 0.00 | $47.67 | -$1.45M | SELL-OPTIONS | 0.00% | 33.01K | Feb 24 | View |
| Feb 24, 2004 | Brendan A Ford | EVP - CORP. DEVELOPMENT | -4.85K | $37.58 | -$944.49K | SELL | -8.86% | 49.92K | Feb 23 | View |
| Jan 28, 2004 | Mark W Parrish | EVP; GROUP PRES.-PHARM. DISTR | 0.00 | $37.60 | -$408.12K | SELL-OPTIONS | 0.00% | 1.95K | Jan 26 | View |
| Jan 28, 2004 | Jody R Davids | EVP & CHIEF INFORMATION OFFCR. | 0.00 | $48.68 | -$157.20K | SELL-OPTIONS | 0.00% | 620.00 | Jan 26 | View |
| Aug 06, 2003 | David W Raisbeck | DIRECTOR | 2.18K | $56.39 | $122.75K | BUY | ∞ | 978.00 | Aug 04 - Aug 05 | View |
| Aug 05, 2003 | Robert D Walter | CHAIRMAN AND CEO | 40.00K | $56.91 | $2.28M | BUY | 3.39% | 1.22M | Aug 04 | View |
